The Association of the British Pharmaceutical Industry (ABPI) has announced the appointment of Kate Brunner as the chair of Prescription Medicines Code of Practice Authority (PMCPA) Appeal Board.
The current chair William Harbage will step down from the role at the end of 2020, after 15 years in the role.
“The ABPI Board welcomes Kate Brunner into the role of chair of the PMCPA Appeal Board," said Haseeb Ahmad, ABPI President and chair of the ABPI Board.
"Brunner brings a huge breadth of experience to the role, across a wide-ranging legal practice including criminal, regulatory, and healthcare law. I look forward to working with Kate and the PMCPA to ensure there is a smooth transition in the new year.”
Kate Brunner said: “I am delighted to take on such an important role as the independent chair of the PMCPA Appeal Board.
“The PMCPA plays a critical role in upholding the high standards under which the industry operates, and I’m committed to using my experience to champion successful self-regulation in the pharmaceutical industry.”
The self-regulatory body administers the ABPI Code of Practice for the Pharmaceutical Industry.
